PR Newswire - China Telecom Holds Launch of Direct-to-phone Sate...
HONG KONG, May 9, 2024 /PRNewswire/ -- On the afternoon of 8 May, China Telecom launched direct-to-p...
Read morePR Newswire - Infosys and Formula E Strike New Partnership to En...
This multi-year technology association will provide in-race insights, fan engagement, and sustainabi...
Read morePR Newswire - Emeren to Release First Quarter 2024 Financial Res...
STAMFORD, Conn., May 9, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emere...
Read morePR Newswire - Hong Kong artist Prudence Mak, Creator of Chocolat...
SYDNEY, May 9, 2024 /PRNewswire/ -- A highly acclaimed Hong Kong artist Prudence Mak with numerous i...
Read morePR Newswire - Korea Blockchain Week 2024 Announces Esteemed Head...
As Korea rises as the Web3 capital, Korea Blockchain Week 2024 sets out as the platform to naviga...
Read morePR Newswire - Global Times: Cultural center bridges Chinese, Ser...
BEIJING, May 9, 2024 /PRNewswire/ -- In Belgrade, capital of Serbia, a white and modern-looking buil...
Read morePR Newswire - Acer Announces Q1 2024 Net Income at NT$1.20 Billi...
Margins for gross profit, operating income, and net income all grow year-on-year TAIPEI, May 9, 2024...
Read morePR Newswire - KT&G Reports 2024 First Quarter Results; Robus...
Revenue and operating profit decreased YoY due to global inflation and the...
Read morePR Newswire - iQIYI Releases May Holiday Content Consumption Rep...
Popular dramas boost tourism in filming locations BEIJING, May 9, 2024 /PRNewswire/ -- On May 7, iQI...
Read morePR Newswire - Infinitopes' Article in Peer-Reviewed Journal Seek...
Publication in Human Vaccines and Immunotherapeutics highlights progress in understanding tumour bio...
Read morePR Newswire - Aetina Introduces AIP-KQ67 for Enhanced Edge AI Co...
TAIPEI, May 9, 2024 /PRNewswire/ -- Aetina, a leading Edge AI solution provider, continues to deepen...
Read morePR Newswire - Infinitopes' Article in Peer-Reviewed Journal Seek...
Publication in Human Vaccines and Immunotherapeutics highlights progress in understanding tumour bio...
Read more